Rachel Beaulieu

Provide world-class services to airline passengers to achieve customer satisfaction. Oversee a wide range of activities varying from resource management through to people management to ensure seamless operations.

Key Achievements:

• Bestowed with award for demonstrating exceptional team collaboration and work ethic as well as for enforcing safety and security standards.
• Leveraged strong knowledge of medical emergencies and assisted multiple passengers dealing with medical cases while onboard on flights.

Developed strategies for Symbicort and Aclidinium franchise and played key role in advancing sales capability framework and Leadership Selling in RESP Business Unit (BU). Contributed to Continuous Medical Education programs in RESP BU as well as to Area Business Managers and field projects; directed senior sales team during development of National Meeting.

Updated COPD and Asthma Learning&Development curriculum in accordance with Marketing, Medical, and L&D objectives in addition to onboarding materials for new employees.

Analyzed healthcare industry insights to align RESP BU strategic priorities against market performances.

Key Achievements:

• Successfully increased Canadian Symbicort sales by 14% in 2018.
• Devised, implemented, and facilitated workshops for National Sales Meeting, Regional Sales Meetings, and Prework to align business needs with RIA portfolio alongside all Canadian respiratory teams.
• Cultivated and led patient-oriented field sales representatives in addition to educating and influencing 300 employees to adopt Persuasive Language Principles.
• Spearheaded training of 300 medical sales representatives in Asthma and COPD portfolio.
• Undertook market research regarding the role of Moderate and Severe Asthma on patient's QOL in real-life settings

Partnered with Healthcare Professionals (HCPs) to promote Diabetes (Forxiga and Xigduo) and respiratory portfolios (Symbicort, Tudorza and Duaklir) to physicians.Undertook relevant research to identify and maximise business growth opportunities.

Attended Diabetes Update 2016 with Canadian Diabetes Association leaders and specialists and created a professional network of endocrinologists.

Key Achievements:

• Exceeded Forxiga targets by 102% in Quebec and Symbicort targets by 101% in Toronto Downtown.
• Commended for transparent communication, team collaboration, and leadership.
• Empowered patients with many educating documents and devices to ensure proper medical use of their inhalers
• Participated in a market access forum, committing to ensure affordable access to Symbicort for all Canadians
• Communicated clinical trials outcomes, including patient-reported outcomes with the goal of pursuing evidence-based conversations

Leveraged sales skills and promote Cardiology, and Women’s Health portfolio consisting of Xarelto medication and Jaydess and Mirena products to physicians and pharmacists. Demonstrated exceptional professional decorum and utilized strategies to increase awareness of company’s medical products in addition to employing strong patient-centric approach.

Key Achievements:

• Pioneered pilot project in collaboration with cardiologists and anticoagulation therapy pharmacists and increased Xarelto sales by 12%.
• Successfully implemented a project with patients living with Atrial Fibrillation intended to seek for QOL improvements over time
• Educating patients on modifiable cardiovascular risk factors including obesity, hypertension, diabetes mellitus, obstructive sleep apnea, alcohol consumption, smoking, and sedentary lifestyles and the link with AFib progression
• Praised for willingness to advance skills and knowledge as well as commitment to improving relations with clients.
• Engaged in patient surveys and market research for Intrauterine Devices (IUD) while working with gynecologists to assess fear of patients